Skip to Main content

ABPI Blogs - Archive

2022

31 January 2022 ABPI analysis on NICE’s changes for evaluating new medicines: Next steps
25 February 2022 By working together we can improve the lives of people with rare diseases
25 February 2022 Moving beyond box-ticking and lip service – why patient involvement matters in a new era of ATMPs for rare diseases
25 February 2022 Alan and Ataxia: Explaining the lived experience of a rare disease
25 February 2022 Diane walks to beat Primary Biliary Cholangitis (PBC)
25 February 2022 Shanali – I am not the illness, I am a person first
28 February 2022 Innovative medicines can bring hope to people with rare diseases – let’s get them to patients
13 April 2022 Worth the wait – The Goldacre review
12 May 2022 Working together, we are all determined to create more medicines for pregnant women
27 June 2022 The Innovative Medicines Fund - Good news for patients but has an opportunity been missed to be more ambitious?
19 October 2022 Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?
02 November 2022 Reflections from NICON22
25 November 2022 By coming together, we can overcome antimicrobial resistance
08 December 2022 Inspiring the next generation of STEM workers

2021

17 February 2021 Evolving the UK health system to support innovation for the rare disease community
17 February 2021 There’s nothing we can’t do or achieve, but people with thalassaemia need understanding and support
26 February 2021 Let's make rare disease treatments less rare
04 March 2021 Our Manifesto for Cymru Wales
04 March 2021 Our Manifesto for Scotland
23 March 2021 A vision for the future of UK clinical research
20 May 2021 Let’s put research at the heart of the NHS
19 August 2021 Our view of the latest NICE Methods & Process Review
25 August 2021 A new strategy for cancer in Northern Ireland
30 September 2021 Invest and innovate to keep UK life sciences globally competitive
22 November 2021 Antibiotic resistance: A global, silent pandemic that is solvable

2020

06 January 2020 How improving Complex Innovative Design trials could get innovative treatments to patients faster
11 February 2020 Industry is leading the drive for research transparency – but we can still do more
17 February 2020 What happens after a medicine has been dispensed matters – here’s why
17 February 2020 Rare bone disease can’t stop speedy Anna
18 February 2020 ‘I don’t let Fabry disease stop me from doing what I want to do'
19 February 2020 Making vaccination an essential service is a step in the right direction
20 February 2020 Early diagnosis is key to improve outcomes for patients
20 February 2020 Rare diseases and clinical research: How can we maximise the chances of success?
20 February 2020 Rare Disease 101 - the first cross-rare disease course for healthcare professionals
20 February 2020 More than just cold hands
20 February 2020 Taking control: Inspiring others to beat rare diseases
20 February 2020 One thing I have learned while living with a rare disease is to never give up
05 March 2020 Levelling up the country means playing to our strengths
29 April 2020 Repurposing what is it and why important for COVID
20 May 2020 International Clinical Trials Day - how is COVID-19 affecting research?
22 May 2020 What new data tells us about Academia-Industry links
25 May 2020 Gavi Partnering to protect future generations from infectious diseases
18 June 2020 Celebrating #WomenInStem for Womenspire
02 October 2020 The Taskforce for Lung Health shows that collaboration gets results
07 October 2020 Research must be for everyone, says ABPI President
02 November 2020 A Global Science Superpower: The Future of Medicines Valuation
11 November 2020 It’s never been more important to tell the great story of vaccines, says ABPI Chief Executive, Richard Torbett

Last modified: 27 January 2025

Last reviewed: 27 January 2025